Esoteric Testing Global Market Report 2023 – By Type (Infectious Diseases Testing, Endocrinology Testing, Oncology Testing, Genetics Testing, Toxicology Testing, Immunology Testing, Neurology Testing, Other Testing), By Technology (Chemiluminescence Immunoassay, Enzyme-Linked Immunosorbent Assay, Mass Spectrometry, Real-Time PCR, DNA (Deoxyribonucleic Acid) Sequencing, Flow Cytometry, Other Technologies ), By End User (Independent And Reference Laboratories, Hospital-Based Laboratories) – Market Size, Trends, And Global Forecast 2023-2032

Testing software refers to the process of confirming and validating whether software or an application is bug-free and satisfies the technical standards established by its design and development. These are software applications used to find errors, bugs, or missing requirements in the software. The main types of testing software market are system integrator and pure play software testing. System integrator are used to carry out to confirm how a software system's module interactions work together. System integrator refers to a sort of software testing used in a combined hardware and software environment to examine how the entire system functions. The different types of components include application testing and services that are used by BFSI, IT and telecom, life sciences and healthcare, manufacturing, energy and utilities, retail, consumer goods, logistics, others. The global testing software market is segmented - 1) By Type: System Integrator, Pureplay Software Testing 2) By Component: Application Testing, Services 3) By End-User: BFSI, IT And Telecom, Life Sciences and Healthcare, Manufacturing, Energy and Utilities, Retail, Consumer Goods, Logistics, Other End Users The global testing software market size is expected to grow from $48.77 billion in 2022 to $52.79 billion in 2023 at a compound annual growth rate (CAGR) of 8.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the testing software is expected to grow to $70.69 billion in 2027 at a CAGR of 7.6%. The surging adoption of smart consumer products is expected to propel the growth of the testing software market going forward. Smart consumer products refer to devices that are connected to the internet, developed for consumers, and can exchange data about themselves, their surroundings, and their users. Automation of software testing is a crucial component of the foundation for smart product online activities. It's a crucial area that takes a lot of attention from individuals in software testing roles online. For instance, according to Earthweb, a US-based online media company, in 2021, 258.54 million smart homes were there globally in the US, of which 23% of broadband households have three or more smart home appliances. Therefore, the surging adoption of smart consumer products is driving the growth of the testing software market. Major players in the testing software market are Tata Consultancy Services Limited, Cognizant Technology Solutions, Capgemini SE, IBM Corporation, Wipro Limited, Infosys Limited, Atos SE, Accenture LLP, Cigniti Technologies Limited, Qualitest Group, Tech Mahindra Ltd., Amdocs LLP, HCL Technologies Limited, DXC Technology Company, Hexaware Technologies Limited, and Gallop Solutions Pvt. Ltd. Technological innovations are a key trend gaining popularity in the testing software market. Major players in the market are creating technologically innovative products to sustain their position in the market. For instance, in October 2020, Applications Software Technology, a US-based systems integrator company, announced the release of version 3.0 of the Autonomous Cloud Tester tool. The unique feature enables organizations to speed up their release, patch, and upgrade test cycles for the entire range of Cloud Applications and cloud-based software. It reduces patch testing time by up to 85%, and broadens the range of customer application footprints that will profit from the service. Organizations can play and pause test results and watch automated processes in action owing to testing execution results that are automatically output in MP4 video format. In February 2021, Qualitest, an Israel-based quality assurance company, acquired QA Infotech for an undisclosed amount. Through this acquisition, Qaulitest aims to expand its current automation testing capabilities, roughly tripling its ability to provide client support via offshore delivery. QA Infotech is an Indian-based company operating in the testing software market. North America was the largest region in the testing software market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the testing software market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the testing software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and the USA. The testing software market includes revenues earned by entities by providing testing services such as functional testing and non- functional testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The testing software report is one of a series of new reports from The Business Research Company that provides testing software statistics, including testing software industry global market size, regional shares, competitors with a testing software share, detailed testing software segments, market trends and opportunities, and any further data you may need to thrive in the testing software industry. This testing software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Central lab is a lab that provides bundled services where all of the samples from the trial's clinical locations are submitted. This ensures that the results and analysis are consistent. The main types of services in the central lab are genetic services, biomarker services, microbiology services, anatomic pathology and histology, specimen management and storage, special chemistry services, and others. Genetic services are services that identify and counsel those who are at risk for genetic abnormalities. The different test types include human and tumor genetics, clinical chemistry, medical microbiology and cytology, and other esoteric tests that are employed in several end-users such as pharmaceutical companies, academic and research institutes, and biotechnology companies. The global central lab market is segmented - 1) By Service Type: Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology or Histology, Specimen Management And Storage, Special Chemistry Services, Other Service Types 2) By Test Type: Human And Tumor Genetics, Clinical Chemistry, Medical Microbiology And Cytology, Other Esoteric Tests 3) By End-User: Pharmaceutical Companies, Academic And Research Institutes, Biotechnology Companies The global central lab market size grew from $2.52 billion in 2022 to $2.74 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global central lab is expected to grow to $3.64 billion in 2027 at a CAGR of 7.3%. The rise in the number of clinical trials is expected to drive the central lab market going forward. A clinical trial is a type of research study that is aimed at evaluating a new treatment, a new drug, or a medical device’s safety and effectiveness. Pharmaceutical and biotechnology companies outsource central labs for testing, development, and production of new products. For instance, according to ClinicalTrials.gov, a registry of clinical trials by the National Library of Medicine and a US-based medical library operated by the US federal government, as of July 2022, 422,646 clinical trials were listed as compared to 399,523 in 2021. Therefore, the rise in the number of clinical trials will promote the central lab market. Major players in the central lab market are Acm Global Laboratories Private Limited, Cerba Research, Sonic Healthcare Limited, Celerion Inc., Cirion Biopharma Research Inc., Clinical Reference Laboratory Inc., Eurofins Central Laboratory LLC, Frontage Laboratories Inc., Icon Central Labs, Interlab Central Lab Services, InVitro International, Labcorp Drug Development India Private Limited, LabConnect LLC, Medpace Clinical Research India Private Limited, MLM Medical Labs GmbH, Synevo Central Lab, and Q2 Solutions Pty Ltd. Technological advancements are a key trend gaining popularity in the central lab market. Major companies operating in the central lab sector are focused on developing new technological solutions to strengthen their position in the market. For example, in December 2021, Instron, a US-based manufacturer of a wide range of cutting-edge materials testing equipment, introduced BluehillCentral Lab management software that allows lab administrators to remotely use Bluehill Central Lab regardless of the quantity or location of test systems. The new Bluehill Central software streamlines the lab administration procedure by managing Instron systems and data at the enterprise level using a single database. With this platform, lab administrators can remotely manage a variety of operations across all the frames on their network, including all Bluehill Universal users and permissions, test method templates, results, file revision approvals, and audit trail information. In December 2021, Thermo Fisher Scientific, a US-based supplier of scientific instrumentation, reagents and consumables, and software services, acquired PPD Inc. for $17.4 billion. The acquisition is expected to strengthen Thermo Fisher's capabilities and help it become an industry leader in clinical research services. PPD, Inc. (Pharmaceutical Product Development), is a US-based contract research organization providing comprehensive, integrated drug development, laboratory, and lifecycle management services. North America was the largest region in the central lab market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the central lab market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the central lab market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The central lab market includes revenues earned by entities by providing services such as specimen management, kit and logistics, and clinical trial data analytics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The central lab market research report is one of a series of new reports from The Business Research Company that provides central lab market statistics, including central lab industry global market size, regional shares, competitors with a central lab market share, detailed central lab market segments, market trends and opportunities, and any further data you may need to thrive in the central lab industry. This central lab market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

SaaS is a software distribution model which allows data to be accessible from any device with an internet connection and a web browser. The software provider hosts and maintains the servers, databases, and code that comprise the application under this web-based approach. The main deployment types of software as a service (SaaS) are public cloud and private cloud. The public cloud is an IT model in which on-demand computing services and infrastructure are managed by a third party and shared by multiple organizations via the public Internet. The software is used by small and medium enterprises (SMEs), large enterprises for customer relationship management (CRM), enterprise resource planning (ERP), human resource management (HRM), manufacturing and operations and supply chain management (SCM). The various end users of the software include manufacturing, retail, education, healthcare, IT and telecom, BFSI and others. The global software as a service (SaaS) market is segmented - 1) By Application: Customer Relationship Management (CRM), Enterprise Resource Planning (ERP), Human Resource Management (HRM), Manufacturing and Operations, Supply Chain Management (SCM) 2) By Deployment Model: Public Cloud, Private Cloud, Hybrid Cloud 3) By Enterprise Size: Small & Medium Enterprises (SMEs), Large Enterprises 4) By End User: Manufacturing, Retail, Education, Healthcare, IT & Telecom, BFSI, Other End-Users The global software as a service (saas) market size will grow from $235.58 billion in 2022 to $253.62 billion in 2023 at a compound annual growth rate (CAGR) of 7.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global software as a service (saas) is expected to grow to $328.03 billion in 2027 at a CAGR of 6.6%. Rapid changes in business dynamics in the market are expected to benefit the software as a service (SaaS) market in the forecast period as cloud-based solutions support business operations in changing conditions. Dynamic market conditions include economic uncertainty, competitive rivalry and the increasing adoption of mobile, changing regulations, internet usage and applications. These conditions along with the increasing number of infrastructures and established networks have forced organizations to pursue scalable and flexible solutions such as SaaS and other cloud-enabled services to run and supervise their operations in a cost-effective and efficient way. These factors have also compelled companies to outsource applications and prefer cloud computing services like SaaS to reduce their cost burden on infrastructure. Companies that seek services from a third-party vendor are more likely to get better performance, compliance and customer satisfaction at a low cost. For example, Sony Communications aims at delivering innovative products and better experiences to its customers using automation and Infosys SaaS solutions. Infosys helped Sony to attain customer loyalty and win competition by providing robust IT solutions and design thinking at a low cost which helped Sony to have a competitive edge in the software as a service (saas) market. Major players in the Software as a Service (SaaS) market are Salesforce, ServiceNow, Microsoft, Google, CisCo., Slack, Adobe, Oracle, Amazon AWS, DocuSign, Zendesk, Dropbox, ADP, Atlassian Confluence, Shopify, Workday, Hubspot, SAP, IBM, Box, Concur, JIRA, GitHub, GoToMeeting, Twilio, CoupaSoftware, Xero and Zuora. Increasing threats on data security especially on cloud platforms are expected to limit the growth of companies in the software as a service market during the forecast period. The threats on data security include industrial espionage and hacking which resulted in multiple breaches of data security involving public cloud environments. These breaches are mainly because of the negligence the cloud service providers. In addition, many companies lack trust in data security when outsourcing from a third-party vendor. As vendor has access to organizations' data, companies fear the misuse of data which might affect the organization's reputation. For example, Code Spaces, a former SaaS provider, discontinued its operations as hackers had access to its cloud services and stole all their data due to which Code Spaces faced damages to its reputation, finances, and business. The introduction of artificial intelligence is gaining popularity in the SaaS market. Artificial Intelligence (AI) is an area of computer science that focus on the simulation of human intelligence processes by machines. AI in SaaS helps companies to upgrade themselves from time to time with the latest data, create better user experience through predictive analytics, automate the areas where manual functions were required previously and personalize user interface features. For example, Oracle, a big player in SaaS market uses AI and machine learning to overtake salesforce in SaaS. This indicates that AI and machine learning would be differentiating factors for the growth of SaaS market. The General Data Protection Regulation (GDPR) break the split of regulations for the security of personal data in the European Union. It makes provisions to protect personal data and privacy of EU citizens for transactions that happen within EU member states. It also regulates the export of personal data outside the EU. There could be data-subjects that patronize the subscriber that are located in the EU, even if a single SaaS subscriber is based in a non-EU location and the SaaS application is based in a non-EU location. This may cause the subscriber to follow the GDPR regulations. For instance, Intercom, a US-based SaaS provider is shortening its time of storing data on visitors to customers' sites by deleting the visitor data if a visitor has not been seen for nine months to comply with the GDPR. In October 2021, Microsoft Corporation acquired Ally.io for an undisclosed amount. With this acquisition, Ally.io has become a member of the Microsoft Viva family as part of its employee experience platform (EXP) designed to assist businesses in embracing the new digital work life. Ally.io is a US-based SaaS startup. North America was the largest region in the Software as a Service (SaaS) market in 2022. Western Europe was the second largest region in the global Software as a Service (SaaS) market share. The regions covered in the global Software as a Service (SaaS) market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the software as a service (SaaS) market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The software as a service (SaaS) market includes revenues earned by entities by providing cloud based software services. SaaS is a software solution that can be purchased on a subscription or pay per use basis to use an application for organizational purposes. Customers can access this application over the internet, mainly through a web browser. All software and application data is located in the service provider's data center. SaaS allows an organization to run an application with minimal upfront costs and accelerates the overall functionality of the organization. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The software as a service (SaaS) market research report is one of a series of new reports from The Business Research Company that provides software as a service (SaaS) market statistics, including software as a service (SaaS) industry global market size, regional shares, competitors with a software as a service (SaaS) market share, detailed software as a service (SaaS) market segments, market trends and opportunities, and any further data you may need to thrive in the software as a service (SaaS) industry. This software as a service (SaaS) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Proteomics is the study of the structure and functions of proteins that are used in drug discovery, diagnosis, and treatment of diseases. Proteomics is used to evaluate the protein production rate, the involvement of proteins in metabolic pathways, and the modifications of proteins. The main types of proteomics are protein microarrays, spectroscopy, X-ray crystallography, chromatography, electrophoresis, surface plasmon resonance, and protein fractionation. The various components used are reagents, instruments, and software that are used for proteomic analytical services and instrument services. The global proteomics market is segmented - 1) By Component: Reagents, Instruments 2) By Instrument: Protein Microarrays, Spectroscopy, X-ray Crystallography, Chromatography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation 3) By Service and Software: Core Proteomics Services, Bioinformatics Software & Services The global proteomics market size grew from $26.98 billion in 2022 to $31.28 billion in 2023 at a compound annual growth rate (CAGR) of 15.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global proteomics is expected to grow from $50.79 billion in 2027 at a CAGR of 12.9%. Rising government funds for research on proteomics drives the growth of the proteomics market. Government funds help researchers in drug discovery, diagnosis, and treatment of diseases. For instance, in 2020, the IRB Barcelona's Mass Spectrometry and Proteomics Core Facility, which is led by a research team with extensive expertise in the field, has received funding from the Catalan government through the European Regional Development Fund (ERDF) to purchase next-generation protein analysis equipment in collaboration with the Josep Carreras Leukemia Research Institute (IJC), the Sant Joan de Déu Research Institute (SJD), the Vall d'Hebron Institute of Oncology (VHIO), and the (UB). Therefore, rising government funds positively impacts the proteomics market. Major players in the proteomics market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Danaher Corporation, Merck KGaA, Waters Corporation, Perkinelmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, GE Healthcare, Caprion Biosciences, Luminex Corporation, LI-COR Inc., Becton Dickinson and Company, Siemens Ltd., Genzyme Corporation, Creative Proteomics, and Promega Corporation. The high cost of instruments is expected to limit the growth of the proteomics market. The broad implementation of new technologies expands the use of proteomics research from the discovery of new drugs, vaccines, and diagnostic targets, and due to its high-cost process, developments in different instruments have resulted in high prices compared to the traditional ones. For instance, the price of mass spectrometers can range from $20,000 to $300,000, which will be extremely expensive for small-scale pharmaceutical companies and academic institutions. Therefore, the high prices associated with proteomics instruments make it difficult for developing countries to enter the proteomics sector, affecting the market’s growth. Companies are launching new products in order to increase their revenue and also gain a competitive edge over their rivals. For instance, in June 2021, Bruker Corporation, a USA-based scientific instruments manufacturing company, announced the availability of two new trapped ion mobility spectrometry time-of-flight (timsTOF) instruments at its 4D-Proteomics eXceed Symposium. The devices, which are based on ion mobility separation and mass spectrometry, will provide additional advances in proteomics, epiproteomics/PTM characterisation, and deep multiomic biomarker discovery. In January 2020, Abcam, a UK-based company specialized in manufacturing research-grade antibodies, acquired Expedeon's proteomics and immunology business for an undisclosed amount. The acquisition is expected to help Abcam enhance its protein conjugation technology and create new products to support research and diagnostic development. Expedeon Ltd. is a UK-based company that specializes in the development of next-generation tools for biological research, diagnostics, and drug discovery. North America was the largest region in the proteomics market in 2022. Western Europe was the second largest region in the global proteomics market share. The regions covered in the global proteomics market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the proteomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The proteomics market consists of sales of proteins that are used for drug discovery, clinical diagnosis, molecular medicine and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The proteomics market research report is one of a series of new reports from The Business Research Company that provides proteomics market statistics, including proteomics industry global market size, regional shares, competitors with a proteomics market share, detailed proteomics market segments, market trends, and opportunities, and any further data you may need to thrive in the proteomics industry. This proteomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Testing, inspection, and certification refer to a conformity analysis for operational efficacy; they catalyse research and development and innovation in new fields through verification and validation; and they establish mutual recognition to ease market access and assure the safety, integrity, and quality of goods and services through conformity evaluation and assurance in various industries. The main types of services provided in testing, inspection, and certification market are testing service, inspection service and certification service. The testing service is a method of determining the presence, quality, or validity of product or goods. Testing, inspection, and certification services can sourced in-house or outsourced and are used for applications such as quality and safety, production evaluation, industrial inspection and system certification. These services are mostly used by industries such as consumer goods and retail, food and agriculture, oil and gas, construction and engineering, energy and chemicals, manufacturing, transportation, industrial and automotive and others. The global testing inspection and certification market is segmented – 1) By Service Type: Testing Service, Inspection Service, Certification Service 2) By Sourcing Type: In-House, Outsourced 3) By Application: Quality And Safety, Production Evaluation, Industrial Inspection, System Certification 4) By End-User: Consumer Goods And Retail, Food And Agriculture, Oil And Gas, Construction And Engineering, Energy And Chemicals, Manufacturing, Transportation, Industrial And Automotive, Other End-Users The global testing, inspection, and certification market size will grow from $223.54 billion in 2022 to $232.8 billion in 2023 at a compound annual growth rate (CAGR) of 4.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the testing, inspection, and certification is expected to grow to $275.16 billion in 2027 at a CAGR of 4.3% The strict regulatory standards imposed by governments to ensure product safety and environmental protection are expected to propel the growth of the testing, inspection, and certification market. The increased risk to human life and the influence on the environment are the main worries, prompting customers to seek dependable and high-quality products. Safety testing, inspection, and certification services are being implemented by many organizations worldwide to resolve product safety and quality problems by following legislative rules. According to the Europe Commission's CO2 emission performance standards for cars and vans in January 2020, regulation (EU), 2019/631 was enforced to set performance standards for new passenger vehicles to decrease the average CO2 emission. Therefore, the strict regulatory standards imposed by governments will drive the testing, inspection, and certification market growth. Major players in the testing, inspection, and certification market are SGS Group, Bureau Veritas, Intertek, Element Materials Technology, TÜV SÜD, Eurofins Scientific, TÜV Rheinland, DEKRA SE, DNV GL, Applus+, ALS Limited, TÜV NORD, IRClass, ASTM, TIC Sera, Hohenstein, BSI Group, SAI Global and AsureQuality. The advent of new technologies in testing, inspection, and certification products and services is a key trend booming the testing, inspection, and certification market. Artificial intelligence is changing corporate operations in practically every sector, including testing, inspection, and certification. Automated inspection is used to satisfy the demands of physically challenging inspection zones. In November 2020, Shanghai introduced the world's first automated laboratory for testing, inspection, and certification, marking a significant milestone for the city to become a global scientific innovation center. The lab uses robotic arms, autonomous guided vehicles, artificial intelligence, and deep learning models to replace the traditional testing and certification procedure, entirely dependent on manual operations. In September 2021, Intertek Group plc, an England-based company offering assurance, inspection, product testing, and certification, acquired SAI Global Assurance, for an undisclosed amount. The acquisition aims to strengthen their combined assurance offering by providing increased scale and geographic coverage in delivering additional risk-based quality audit, inspection, training, and certification services and enhanced global market access capabilities through our standards service offering. SAI Global, a US-based company, offers risk management services, quality assurance audit and certification, auditor training, standards information services, and property service. Asia-Pacific was the largest region in the testing, inspection and certification market in 2022. The regions covered in the testing, inspection and certification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the testing, inspection and certification market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The testing, inspection, and certification market includes revenues earned by entities by providing conformity assessment services for good practices. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The testing, inspection, and certification market research report is one of a series of new reports from The Business Research Company that provides testing, inspection, and certification market statistics, including testing, inspection, and certification industry global market size, regional shares, competitors with an testing, inspection, and certification market share, detailed testing, inspection, and certification market segments, market trends and opportunities, and any further data you may need to thrive in the testing, inspection, and certification industry. This testing, inspection, and certification market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Precision diagnostics refers to a subspecialty of precision medicine that provides healthcare leveraging individual data, such as genetic, environmental, and lifestyle information, to enhance illness prevention, diagnosis, and treatment. It is employed to provide more genetic information about a patient's clinical history for studies that may benefit in the treatment process. The main types of precision diagnostics are genetic tests, esoteric tests, and others. Genetic tests refer to laboratory tests to look for differences in an individual's DNA such as alterations to a person's chromosomes, genes, or gene expression in their cells or tissues. The various technology includes next-generation sequencing (NGS), polymerase chain reaction (PCR), in situ hybridization (ISH), mass spectrometry, immunohistochemistry (IHC), and others. These are used in various applications such as oncology, infectious diseases, cardiovascular, neurology, and genetic disorders, and others and are used by hospitals and clinics, diagnostic laboratories, research institutes, pharmaceutical and biotechnology companies, and others. The global precision diagnostics market is segmented - 1) By Type: Genetic Tests, Esoteric tests, Other Types 2) By Technology: Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Mass Spectrometry, Immunohistochemistry (IHC), Other Technologies 3) By Application: Oncology, Infectious diseases, Cardiovascular, Neurology, Genetic disorders, Other Applications 4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical and biotechnology Companies, Other End-Users The global precision diagnostics market size is expected to grow from $75.28 billion in 2022 to $85.73 billion in 2023 at a compound annual growth rate (CAGR) of 13.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of precision diagnostics market is expected to reach $142.53 billion in 2027 at a CAGR of 13.6%. The rising prevalence of chronic diseases is expected to propel the growth of the precision diagnostics market going forward. A chronic disease is a form of illness that lasts three months or more and can deteriorate with time. Precision diagnostics help patients suffering from chronic diseases such as cancer and cardiovascular diseases by precisely managing a patient's healthcare model and diagnosing the disease with accurate results. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least one chronic condition would increase by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Therefore, the rising prevalence of chronic diseases is driving the growth of the precision diagnostics market. Major players in the precision diagnostics market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Abbott Laboratories, Danaher Corporation, Amgen Inc., Koninklijke Philips N.V., Becton Dickinson and Company (BD), Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Siemens Healthineers AG, Agilent Technologies Inc., PerkinElmer Inc., Beckman Coulter Inc., Charles River Laboratories International Inc., Sysmex America Inc., Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Bio-Techne Corporation, Illumina Inc., Lantheus Medical Imaging Inc., Luminex Corporation, BioFire Diagnostics LLC, Genomic Health Inc., Swiss Precision Diagnostics GmbH, and Bluebird Bio Inc. The introduction of innovative therapy is a key trend gaining popularity in the personalized medicine market. Major companies operating in the precision diagnostics market are adopting new technologies to sustain their position in the market. For instance, in July 2021, Xyall BV, a Netherlands-based automated tissue dissection solution company, launched Automated High Throughput (HT) system for greater precision diagnostics. This is a first in the world, allowing high-volume molecular diagnostic laboratories to commercialize the company's unique, automated tissue dissection technology. In February 2022, SQI Diagnostics Inc., a Canada-based precision medicine company, acquired Precision Biomonitoring Inc. for $6,825,000. With this acquisition, SQL aims to expand its human diagnostic business portfolio along with TripleLock molecular diagnostic testing technology. Precision Biomonitoring Inc. is Canada-based biotechnology and research company that provides precision diagnostic services, including DNA-based surveillance and detection. North America was the largest region in the precision diagnostics market in 2022. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in precision diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the precision diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The precision diagnostics market consists of revenues earned by entities by providing precision imaging, molecular imaging, on-device X-ray AI algorithms, and automated MR workflow. The market value includes the value of related goods sold by the service provider or included within the service offering. The precision diagnostics market also includes sales of medical diagnostic kits, rapid test kits, instruments and analyzers, and diagnostic equipment which are used in precision diagnostics services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The precision diagnostics market research report is one of a series of new reports from The Business Research Company that provides precision diagnostics market statistics, including precision diagnostics industry global market size, regional shares, competitors with a precision diagnostics market share, detailed precision diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the precision diagnostics industry. This precision diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Barrett's esophagus is the medical term for a condition in which acid reflux harms the flat pink lining of the swallowing tube, which connects the mouth to the stomach. This affects the lining, causing it to thicken and turn red. Barrett's esophagus is more resistant to stomach acid than squamous cells and intestinal cells, indicating that tissue alterations take place to shield the esophagus from acid exposure. This illness affects men more often than women and white people. The main barrett’s esophagus types are no dysplasia, low-grade dysplasia, high grade dysplasia, and others. No dysplasia refers to column-like cells, including goblets that are blue and filled with mucin. The various treatments are medication, endoscopic therapy, surgery, and others with route of administration such as oral, parenteral, rectal, and others. The various distribution channels are hospital pharmacy, retail pharmacy, online pharmacy, and others. The global barrett esophagus market is segmented - 1) By Type: No Dysplasia, Low-Grade Dysplasia, High Grade Dysplasia, Other Types 2) By Treatment: Medication, Endoscopic Therapy, Surgery, Other Treatments 3) By Route Of Administration: Oral, Parenteral, Rectal, Other Routes Of Administration 4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels The global barrett esophagus market size is expected to grow from $5.66 billion in 2022 to $5.98 billion in 2023 at a compound annual growth rate (CAGR) of 5.60%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of barrett esophagus market is expected to reach $7.54 billion in 2027 at a CAGR of 5.97%. Increased chances of esophageal cancer are expected to propel the growth of barrett esophagus market going forward. Esophageal cancer refers to a type of cancer that affects the esophagus, a long, hollow tube that connects the throat to the stomach. The rise in esophageal cancer occurs in patients with Barrett's esophagus with dysplasia. However, the chance of developing esophageal cancer is higher in people with high-grade dysplasia in Barrett's esophagus. For instance, in 2023, according to the American Cancer Society, a US-based cancer-fighting organization that provides patient support, research, and advocacy for cancer care, esophageal cancer will affect an estimated 21,560 people in 2023, compared to 20,640 people affected in 2022. Therefore, an increase in the chance of esophageal cancer is driving the growth of barrett esophagus market. Major players in the barrett esophagus market are F Hoffmann-La Roche Ltd., Sanofi SA, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Medtronic PLC., Merck KGaA, Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, AdventHealth Medical Group, Olympus Corporation, Eisai Co. Ltd., Steris plc, Aurobindo Pharma Limited, Cook Medical Inc., Endo International plc, Sun Pharmaceutical Industries Limited, Ironwood Pharmaceuticals Inc., Spectrum Health System, Sebela Pharmaceuticals Inc., Phathom Pharmaceuticals Inc., EndoGastric Solutions Inc., NinePoint Medical Inc., Mederi Therapeutics Inc., SRS Pharmaceuticals Pvt. Ltd, Pinnacle Biologics Inc., Addex Therapeutics Ltd., Johnson & Johnson Private Limited, SpectraScience Inc., and Zydus Group. Product innovations are the key trends gaining popularity in barrett esophagus market. Major companies operating in barrett esophagus market are focusing on developing new innovative products to sustain their position in the market. For instance, in February 2020, PAVmed Inc., a US-based commercial-stage medical technology company, launched EsoCheck and EsoGuard, a device and test that is created for the detection of Barrett's esophagus. It allows patients to identify the risk for esophageal cancer with the 5-minute office-based test. In December 2021, Castle Biosciences, Inc., a US-based diagnostics company focused on improving illness management, acquired Cernostics for approximately $1 billion. The acquisition is subject to expanding its business operations, entering new markets, or gaining access to innovative technologies or expertise. Cernostics, Inc. is a US-based molecular diagnostic company that provides the detection of esophageal cancer in barrett’s esophagus patients. North America was the largest region in the barrett esophagus market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in barrett’s esophagus report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the barrett esophagus market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The barrett esophagus market includes revenues earned by entities by providing pathology services, treatment services and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The barrett esophagus market research report is one of a series of new reports from The Business Research Company that provides barrett esophagus market statistics, including barrett esophagus industry global market size, regional shares, competitors with a barrett esophagus market share, detailed barrett esophagus market segments, barrett esophagus market trends and opportunities, and any further data you may need to thrive in the barrett esophagus industry. This barrett’s esophagus esophagus market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Bioresorbable medical materials refer to materials that are designed to be absorbed or broken down by the body over time. These materials are used in various medical applications, such as surgical implants and tissue engineering scaffolds, that offer several advantages over permanent implants and eliminate the need for surgical removal once the desired function is achieved. The main types of bioresorbable medical materials are polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, polycaprolactone (PCL), and polylactic-co-glycolic acid (PLGA). Polylactic acid (PLA) is a biodegradable and bioresorbable polymer derived from renewable sources such as corn starch or sugarcane and is commonly used in bioresorbable medical materials, including sutures, screws, and bone fixation devices. These materials are used in several applications, such as drug delivery, orthopedics, and others, by end-users, including hospitals and clinics, ambulatory surgical centers, research institutes, and others. The global bioresorbable medical material market is segmented - 1) By Type: Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polysaccharides, Polycaprolactone (PCL), Poly Lactic-Co-Glycolic Acid (PLGA) 2) By Application: Drug Delivery, Orthopedics, Other Applications 3) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End-Users The global bioresorbable medical material market is expected to grow from $1.26 billion in 2022 to $1.4 billion in 2023 at a compound annual growth rate (CAGR) of 11.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global bioresorbable medical material is expected to reach $2.04 billion in 2027 at a CAGR of 9.9%. The increasing number of surgeries is expected to propel the growth of the bioresorbable medical material market going forward. Surgical procedures refer to medical treatment that involves making an incision and using tools to stop or repair disease in a living body. Bioresorbable polymers are used in molded medical equipment, particularly those used in neurology, orthopedics, and cosmetic surgery. Bioresorbable materials can be used to make sutures, anchors, and screws. For instance, in 2022, according to the British Heart Foundation, a UK-based cardiovascular research charity. states that in UK surgical procedures, transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation (TAVI) surgeries, increased from 5,676 in 2019/20 to 6,328 in 2020/21. Therefore, the increasing number of surgeries is driving the growth of the bioresorbable medical material market. Major players in the bioresorbable medical material market are Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Kureha Corporation, Evonik Industries AG, Stryker Corporation, Toray Industries Inc., Mitsui Chemicals Inc., Arkema S.A., Royal DSM N.V., Zimmer Biomet Holdings Inc., COFCO Biotechnology Co. Ltd., Ashland Global Holdings Inc., Corbion N.V., Zeus Industrial Products Inc., Unitika Ltd., Danimer Scientific, Synbra Technology, KLS Martin Group, Durect Corporation, Putnam Plastics Corporation, Zhejiang Haizheng Biomaterials Co. Ltd., Shenzhen eSUN Industrial Co. Ltd., NatureWorks LLC, Foster Corporation, Poly-Med Inc., Futerro S.A., and TotalEnergies Corbion B.V. The introduction of novel biomaterials is a key trend gaining popularity in the bioresorbable medical material market. Major companies operating in the bioresorbable medical material market are focused on developing novel biomaterials for 3D printing applications to sustain their position in the market. For instance, in February 2020, Evonik Industries AG, a Germany-based specialty chemicals company specializing in bioresorbable materials, introduced RESOMER PrintPowder, the bioresorbable material in powder form suited for high-resolution 3D printing of implanted medical devices using selective laser sintering (SLS) machinery. This innovative product is a finely tuned, free-flowing powder with stringent specifications and an optimized particle size distribution. The exceptional flow properties of RESOMER PrintPowder enable medical device companies to leverage SLS 3D printing technologies to fabricate intricate bioresorbable implants with precisely customized mechanical characteristics. In July 2021, BD (Becton, Dickinson, and Company), a US-based medical technology company, acquired Tepha Inc. for an undisclosed amount. This acquisition increases BD's surgical mesh portfolio's expansion rate and propels the business into potential new soft tissue repair, reconstruction, and regeneration markets. Tepha Inc. is a US-based producer of medical devices and bioresorbable scaffolds for soft tissue repair. North America was the largest region in the bioresorbable medical material market in 2022. Asia-Pacific is expected to be the fastest-growing region in the bioresorbable medical material market report during the forecast period. The regions covered in the bioresorbable medical materials report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the bioresorbable medical materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The bioresorbable medical materials market consists of sales of chitosan, collagen, and calcium phosphates. Values in this market are ‘factory gat’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The bioresorbable medical material research report is one of a series of new reports from The Business Research Company that provides bioresorbable medical material market statistics, including the bioresorbable medical material industry's global market size, regional shares, competitors with a bioresorbable medical material market share, detailed bioresorbable medical material market segments, market trends and opportunities, and any further data you may need to thrive in the bioresorbable medical material industry. This bioresorbable medical material market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.